Lamivir HBV

Lamivir Hbv Tablet is used for Hepatitis b virus infection, Hiv infection, Hepatitis b infections and other conditions. This Tablet may also be used for purposes not listed in this medication guide.

This Tablet contains Lamivudine as an active ingredient.

This Tablet works by increasing the number of infection fighting cells in the body.

Cipla manufactures This Tablet.

Detailed information related to This Tablet’s uses, composition, dosage, side effects and reviews is listed below.

What is Lamivir HBV 100mg Tablet?

Lamivir 100 mg Tablet is an antiviral medicine which is used to treat human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections. This medicine is not a cure for HIV. It only prevents the virus from multiplying in your body. Monitoring of liver function and kidney function may be necessary while receiving this medicine based on the clinical condition.

Instruction for Lamivir HBV 100mg

Take Lamivir 100 mg Tablet exactly as instructed by the doctor. Do not take in larger or smaller quantities than recommended. Ensure that proper hygiene measures are adopted. Complete the course of treatment to prevent the spread of the infection. Close monitoring of liver function and kidney function may be necessary while receiving this medicine based on the clinical condition.

Drug interaction of Lamivir HBV 100mg

Interaction with Alcohol

• Description – Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
• Instructions – Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Interaction with Medicine

• Methotrexate
• Efavirenz

Side Effects of Lamivir HBV 100mg

• diarrhea
• headache
• fatigue
• chills
• nausea
• vomiting
• loss of appetite
• dizziness
• trouble sleeping
• depression
• stuffy nose
• cough
• rash
• stomach pain
• vomiting (in children)
• nausea (in children)
• fever
• muscle pain
• numbness, tingling, or burning in the fingers or toes

Warning And Precaution of Lamivir HBV 100mg tablet

The warnings and precautions associated with Lamivudine (Generic Epivir and Generic Epivir HBV) therapy are:

Co-infected HIV-1/HBV Patients: Emergence of Lamivudine-resistant HBV variants associated with lamivudine-containing antiretroviral regimens has been reported.

Emtricitabine-containing products should not be administered concomitantly with Lamivudine-containing products.

Hepatic decompensation, some fatal, has occurred in HIV-1/HCV co-infected patients receiving interferon and Ribavirin-based regimens.

Monitor for treatment-associated toxicities. Discontinue Lamivir HBV and Lamivir as medically appropriate and consider dose reduction or discontinuation of interferon alfa, Ribavirin, or both.

Pancreatitis: Use with caution in pediatric patients with a history of pancreatitis or other significant risk factors for pancreatitis. Discontinue treatment as clinically appropriate.

Immune reconstitution syndrome and redistribution/accumulation of body fat have been reported in patients treated with combination antiretroviral therapy.

In patients with moderate to severe renal impairment, serum Lamivudine concentrations (AUC) are increased due to decreased renal clearance, therefore the dose should be reduced for patients with a creatinine clearance of less than 50 mL/minute.

Cases of lactic acidosis, usually associated with severe hepatomegaly and hepatic steatosis, have been reported with the use of combination nucleoside analog therapy in patients with HIV.

Lamivir HBV 100mg Dosage

The recommended oral dose of Lamivudine HBV(Generic Epivir HBV) for the treatment of chronic hepatitis B in adults is 100 mg once daily. Safety and effectiveness of treatment of Lamivir- HBV beyond 1 year have not been established and the optimum duration of treatment is not known.

The recommended oral dose of Lamivudine tablets (Generic Epivir) in HIV-1 infected adults and adolescents greater than 16 years of age is 300 mg daily, administered as either Lamivir 150 mg twice daily or 300 mg once daily, in combination with other antiretroviral agents.

If Lamivudine tablets are administered to a patient infected with HIV-1 and HBV, the dosage indicated for HIV-1 therapy must be used as part of an appropriate combination regimen.

Uses of Lamivir HBV 100mg

Lamivudine tablets (Lamivir HBV and Lamivir) is used for the treatment of chronic hepatitis B virus infection associated with evidence of hepatitis B viral replication and active liver inflammation. This medicine is also used along with other medicines to treat human immunodeficiency virus (HIV) infection.

Lamivir HBV tablets and Lamivir tablets (Generic Epivir HBV and Generic Epivir) are manufactured by Cipla Ltd. in the strengths of 100 mg and 150 mg respectively.

Storage of Lamivir HBV 100mg

Store Lamivir HBV and Lamivir at controlled room temperature (59°F to 86°F, 15°C to 30°C).

Protect from light.